Innova Captab Expands Baddi Plant by Rs 45 Crore

Innova Captab’s board of directors formally approved a brownfield expansion for its Baddi manufacturing plant during a meeting held on August 21, 2026. This strategic move is set to introduce two new production lines dedicated to oral solid dosage, marking a significant investment in the company’s operational capacity.

Key Project Specifications

The comprehensive expansion project is slated for a total investment of Rs 45 crore. Innova Captab intends to finance this substantial project through a combination of its existing internal accruals and readily available bank credit facilities, ensuring a robust funding strategy.

• Investment: Rs 45 crore
• New Additions: Two oral solid dosage production lines
• Funding Sources: Internal accruals and bank credit facilities
• Location: Baddi manufacturing plant
• Approval Date: August 21, 2026

The addition of these two new oral solid dosage production lines underscores Innova Captab’s commitment to enhancing its manufacturing capabilities and expanding its product offerings within the pharmaceutical sector. This targeted expansion focuses on a critical area of drug formulation.

This investment is poised to bolster Innova Captab’s production capacity at its Baddi facility, aligning with future market demands and reinforcing its position in the oral solid dosage segment. The move highlights a clear strategy for growth and operational scaling.